Optos Celebrates Global Milestone of 30,000 Devices Installed and Recognises Radiance Eye Care for Enhancing Patient Care

Dunfermline, UK — 25, June 2026 – Optos PLC, a pioneering leader in retinal imaging technology, today announced a major global milestone of 30,000 devices installed worldwide. For more than 30 years, Optos has played a critical role in progressing retinal imaging and supporting improved patient care worldwide.

Alexandre Montague, Chief Executive Officer of Optos, remarks, “When clinicians can see more of the retina, they are better equipped to detect and monitor systemic and ocular disease. Practices like Radiance Eye Care demonstrate what’s possible when innovation is paired with a deep commitment to patient outcomes. It’s not just about improving vision—it’s about protecting health, saving sight, and in many cases, saving lives.”

As the market leading single-capture, 200-degree ultra-widefield (UWF™) retinal imaging technology, Optos has enabled clinicians to visualise and document the retina in ever-evolving ways to elevate patient care.

As part of this milestone, Optos is proud to recognise Radiance Eye Care, a member of the Vision Source network for their meaningful impact on comprehensive eyecare. By incorporating optomap UWF imaging into routine exams, the practice has strengthened its ability to support better patient outcomes.

“As a Vision Source member, we are focused on delivering the highest standard of care through innovation and collaboration,” said Toral Patel, OD, Radiance Eye Care. “Having access to Optos technology allows us to better educate our patients, identify concerns, and take a more proactive approach to eye care. That ultimately means we can do more to protect our patients’ vision and overall health.”

With ten imaging modalities available across its platforms, Optos continues to expand its capabilities. Designed to integrate seamlessly across multiple care settings—in telehealth, optometry, ophthalmology, retina specialty practices, and large multi-site health centers—Optos technology supports efficient workflows while maintaining the highest standards of diagnostic quality. This commitment to innovation, usability, and clinical impact continues to drive progress in ophthalmic imaging around the world.

For more than three decades, Optos has remained focused on empowering eye care professionals, improving access to advanced imaging, and helping shape a future where patient outcomes are ultimately improved globally.

 

For more information about Optos, visit www.optos.com. 

  

For more than 30 years, Optos has been the market-leading provider of 200-degree single-capture, ultra-widefield retinal imaging systems to eye care professionals worldwide. With over 30,000 devices in use globally and supported by more than 4,000 clinical papers, Optos has also developed integrated ultra-widefield retinal imaging with optomap-guided Optical Coherence Tomography (OCT). Optos technology facilitates the pathology detection, management, and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. As a leader in retinal imaging technology, Optos continues to set the standard for excellence and innovation in eye care.